Last reviewed · How we verify
Intra-tympanic injection of drugs
Intra-tympanic injection of drugs is a Small molecule drug developed by saad elzayat. It is currently in Phase 1 development. Also known as: Lidocaine in tinnitus.
At a glance
| Generic name | Intra-tympanic injection of drugs |
|---|---|
| Also known as | Lidocaine in tinnitus |
| Sponsor | saad elzayat |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Intra-tympanic injection of drugs CI brief — competitive landscape report
- Intra-tympanic injection of drugs updates RSS · CI watch RSS
- saad elzayat portfolio CI
Frequently asked questions about Intra-tympanic injection of drugs
What is Intra-tympanic injection of drugs?
Intra-tympanic injection of drugs is a Small molecule drug developed by saad elzayat.
Who makes Intra-tympanic injection of drugs?
Intra-tympanic injection of drugs is developed by saad elzayat (see full saad elzayat pipeline at /company/saad-elzayat).
Is Intra-tympanic injection of drugs also known as anything else?
Intra-tympanic injection of drugs is also known as Lidocaine in tinnitus.
What development phase is Intra-tympanic injection of drugs in?
Intra-tympanic injection of drugs is in Phase 1.
Related
- Manufacturer: saad elzayat — full pipeline
- Also known as: Lidocaine in tinnitus
- Compare: Intra-tympanic injection of drugs vs similar drugs
- Pricing: Intra-tympanic injection of drugs cost, discount & access